Bearish flow noted in Iovance Biotherapeutics with 5,142 puts trading, or 19x expected. Most active are Aug-24 8.5 puts and 8/30 weekly 8.5 calls, with total volume in those strikes near 5,400 contracts. The Put/Call Ratio is 2.51, while ATM IV is up over 3 points on the day. Earnings are expected on August 6th.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics put volume heavy and directionally bearish
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics submits MAA to EMA for lifileucel